Evidence map›Paper›PMID 28031957›Full record

ReviewFuture science OA2016

The role of the histoblood ABO group in cancer.

Seth K Rummel, Rachel E Ellsworth

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Future science OA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06149923 (Association Between ABO Polymorphism and Gastric/Colorectal Cancers), which is not on this map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06149923 unknown statusnot on this mapstarted 2023, after this paper: background citation

Association Between ABO Polymorphism and Gastric/Colorectal Cancers

TypeobservationalSponsorAssiut UniversityRan2023 to 2026Enrolled184ConditionsGastric Cancer, Colo-rectal CancerArmsquantitative Real-time PCR
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. [ABO incompatibility and complications in hematopoietic stem cell transplantation].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A Novel c.796 A>C Mutation in theTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Seth K RummelClinical Breast Care Project, Windber Research Institute, 620 Seventh Street, Windber, PA 15963, USA; Clinical Breast Care Project, Windber Research Institute, 620 Seventh Street, Windber, PA 15963, USA.
Rachel E EllsworthClinical Breast Care Project, Murtha Cancer Center, 620 Seventh Street, Windber, PA 15963, USA; Clinical Breast Care Project, Murtha Cancer Center, 620 Seventh Street, Windber, PA 15963, USA.
Breast Cancer Care · GBWindber Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first link between blood type and cancer was described in 1953, numerous studies have sought to determine whether the histoblood ABO group is associated with tumorigenesis. In 2009, the first significant association between a SNP located within the ABO glycosyltransferase gene and increased risk of pancreatic cancer was reported. Here, we describe the history and possible functions of the histoblood ABO group and then provide evidence for a role of blood group antigens in the most common cancer types worldwide using both blood type and SNP data. We also explore whether confusion regarding the role of blood type in cancer risk may be attributable to heterogeneity within tumor types.

Indexed as

cancerhistoblood ABO grouprs505922

Identifiers

PMID28031957
PMCPMC5137991
OpenAlexW2298084343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.